Strolll

Strolll develops digital therapeutics software using augmented reality (AR) glasses to improve movement therapy for individuals with neurological disorders such as Parkinson's disease, stroke, and Multiple Sclerosis. Their platform enables immersive rehabilitation in both clinical and home settings, providing objective data and remote monitoring to personalize care and improve mobility.

  • Augmented & Virtual Reality
  • Digital Health
  • Neuroscience
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Sep 3, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Sep 3, 2026

    GBP -1

    Series A

    Led by IW Capital

    • IW Capital
    • Cleveland Clinic
    • Future Planet Capital Regional

    Article coming soon.

Pricing

Research Strolll — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Strolll is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational